ROBINSON JAMES GEORGE purchased 0.3% of their position (11K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $17.1K — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 6/6/2019ACC: 0001651844-19-000007
Director
Since Oct 2018
+11K
Net shares
Net buyer
$17.1K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
11K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+200.00
Price / share
$1.52
Trade value
$305.00
% of position
0.0%
6/5/2019
3.36M→3.36M
Common Stock
Direct
Shares
+400.00
Price / share
$1.53
Trade value
$611.00
% of position
0.0%
6/5/2019
3.36M→3.36M
Common Stock
Direct
Shares
+1.86K
Price / share
$1.54
Trade value
$2.87K
% of position
0.1%
6/5/2019
3.36M→3.37M
Common Stock
Direct
Shares
+1K
Price / share
$1.55
Trade value
$1.55K
% of position
0.0%
6/5/2019
3.37M→3.37M
Common Stock
Direct
Shares
+7.54K
Price / share
$1.56
Trade value
$11.76K
% of position
0.2%
6/5/2019
3.37M→3.37M
Total
Net shares
+11K
Net value
$17.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2019 | P · Purchase | +200.00 | $1.52 | $305.00 | 0.0% | 3.36M | 3.36M |
| Common Stock Direct | 6/5/2019 | P · Purchase | +400.00 | $1.53 | $611.00 | 0.0% | 3.36M | 3.36M |
| Common Stock Direct | 6/5/2019 | P · Purchase | +1.86K | $1.54 | $2.87K | 0.1% | 3.36M | 3.37M |
| Common Stock Direct | 6/5/2019 | P · Purchase | +1K | $1.55 | $1.55K | 0.0% | 3.37M | 3.37M |
| Common Stock Direct | 6/5/2019 | P · Purchase | +7.54K | $1.56 | $11.76K | 0.2% | 3.37M | 3.37M |
| Total | +11K | $17.09K | ||||||
Derivative Transactions0
No derivative transactions reported